Clinical Trial Update: Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer

View source ↗

Summary

A completed study comparing universal germline genetic testing with guidelines-directed testing in non-Western breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: King Hussein Cancer Center | Conditions: Breast Cancer | Status: COMPLETED